跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 109,281 条关于
“HER2-mutated lung cancer”
全部
109,281
临床试验
89,245
药物
2,674
机构
1,160
资讯
16,202
去年
Boehringer Ingelheim Prepares for Multiple New Product Launches in 2025 Following Strong R&D Investment
2年前
Zongertinib Shows Promise in HER2-Mutated NSCLC: Boehringer Ingelheim Reports Positive Phase Ib Results
去年
Trastuzumab Deruxtecan Shows Promise in HER2-Mutated NSCLC
去年
HER2-Targeted Therapies Evolve in NSCLC Treatment Landscape
11个月前
Bayer's Hyrnuo Receives FDA Approval for HER2-Mutated Non-Small-Cell Lung Cancer
去年
Datopotamab Deruxtecan Granted FDA Breakthrough Therapy Designation for EGFR-Mutated NSCLC
7个月前
Boehringer Ingelheim Discontinues Cystic Fibrosis Gene Therapy While Advancing €25 Billion R&D Investment Plan
6个月前
BlossomHill Therapeutics Unveils Next-Generation Pan-KRAS Inhibitors with Picomolar Potency at AACR 2026
去年
Bayer's BAY 2927088 Advances to Phase 3 Trial for HER2-Mutated NSCLC
8个月前
Bayer Expands Genetic Medicine Portfolio Through Strategic siRNA and AI Partnerships
第 1 页,共 1621 页
上一页
下一页